The team used nuclear magnetic resonance spectroscopy, 3D modelling and cell-based assays to observe the interaction between the virus and host cells.
"We found that a human strain previously through insensitive to sialidase does in fact recognise and bind to sialic acid, but it is a sialic acid not accessible to sialidase treatment." Professor von Itzstein said.
"This reveals that there is a common chink in the armour of these rotaviruses.
"This discovery is the first step in designing a broad-spectrum drug able to exploit this weakness to combat many types of human and animal rotaviruses."
'/>"/>
| Contact: Jeannette Langan j.langan@griffith.edu.au 61-755-528-654 Research Australia Source:Eurekalert |